Vitamin B12 reverses developmental defects in worm model of Verheij syndrome

Researchers report that vitamin B12 largely corrected abnormalities in C. elegans carrying a mutation linked to Verheij syndrome, with analogous metabolic changes also detected in human patients with the condition.

Published · AI-drafted summary based on 1 public source
Illustration for rare disease story
Illustrative image — not from the source article.
Share

A study reported by ScienceDaily describes how vitamin B12 supplementation substantially reversed developmental abnormalities in Caenorhabditis elegans engineered to carry a mutation associated with Verheij syndrome — a rare autosomal recessive disorder characterised by growth retardation, intellectual disability, and structural anomalies. The researchers also identified similar metabolic perturbations in a small cohort of human patients with Verheij syndrome, suggesting the worm model may capture relevant biology.

Verheij syndrome is caused by variants affecting the PUF60 gene and related loci on chromosome 8q24. The proposed mechanism centres on disruption of one-carbon metabolism, in which vitamin B12 plays a central co-factor role. By supplementing B12, the team report they were able to partially restore normal development in the worm system.

The primary journal source was not specified in the available lede; the report is based on a ScienceDaily press release. The findings are of interest to rare-disease researchers and those working on metabolic supplementation strategies for Mendelian disorders, as well as genetic counsellors and clinicians managing patients with Verheij syndrome. Importantly, animal model results do not translate automatically into clinical practice: published guidance from treating clinicians and relevant specialist bodies would need to be consulted before any supplementation approach is considered in patients. The work nonetheless illustrates the utility of invertebrate models in identifying candidate metabolic interventions for rare genetic diseases.

Plain-language version

For patients, families, and general readers. Educational only — not medical advice.

Researchers have found that adding vitamin B12 to the diet of a small roundworm — a model organism widely used in genetics research — largely reversed developmental problems caused by a genetic mutation linked to Verheij syndrome. Verheij syndrome is a rare condition caused by changes in certain genes that affect growth and development. The same kind of metabolic problem seen in the worms was also found in a small group of people with Verheij syndrome, which suggests the finding may be relevant to humans.

This is early-stage research. Results in worms do not automatically mean that vitamin B12 supplements would help people with Verheij syndrome, and no clinical recommendations have been made on the basis of this study alone. Researchers would need to carry out further work, including studies in people, before any conclusions about treatment could be drawn.

This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source ScienceDaily · 2026-11-16
    Vitamin B12 may hold the key to treating a rare genetic disorder

Tags

verheij-syndrome puf60 vitamin-b12 one-carbon-metabolism rare-disease c-elegans metabolic-supplementation
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List